Ventiv Health said this week that it is changing its corporate brand name to inVentiv Health as part of a rebranding initiative that began when Ventiv Health acquired inChord Communications in Oct. 2005.
InVentiv has organized itself into three business segments: inVentiv Clinical, inVentiv Communications and inVentiv Commercial.
Meanwhile, Ventiv Health acquired the Canadian healthcare marketing and communications agency Jeffrey Simbrow Associates Inc. (JSAI) and clinical trial management service Synergos.
Under the terms of the JSAI deal, Ventiv will acquire JSAI for $10 million in cash and stock, plus earn-out payments for exceeding specified financial targets. The transaction is expected to close at the beginning of April.
Synergos was acquired for $5.8 million in cash and stock, Ventiv said.